Glaukos Corp (GKOS)
107.98
+2.97
(+2.83%)
USD |
NYSE |
May 07, 16:00
98.00
-9.98
(-9.24%)
Pre-Market: 20:00
Glaukos Revenue (Quarterly): 85.62M for March 31, 2024
Revenue (Quarterly) Chart
Historical Revenue (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2024 | 85.62M |
| December 31, 2023 | 82.36M |
| September 30, 2023 | 78.05M |
| June 30, 2023 | 80.40M |
| March 31, 2023 | 73.90M |
| December 31, 2022 | 71.23M |
| September 30, 2022 | 71.27M |
| June 30, 2022 | 72.68M |
| March 31, 2022 | 67.68M |
| December 31, 2021 | 73.24M |
| September 30, 2021 | 74.71M |
| June 30, 2021 | 78.09M |
| March 31, 2021 | 67.97M |
| December 31, 2020 | 73.23M |
| September 30, 2020 | 64.83M |
| June 30, 2020 | 31.56M |
| March 31, 2020 | 55.34M |
| December 31, 2019 | 65.85M |
| September 30, 2019 | 58.51M |
| June 30, 2019 | 58.60M |
| March 31, 2019 | 54.03M |
| Date | Value |
|---|---|
| December 31, 2018 | 54.08M |
| September 30, 2018 | 43.91M |
| June 30, 2018 | 43.16M |
| March 31, 2018 | 40.13M |
| December 31, 2017 | 41.65M |
| September 30, 2017 | 40.41M |
| June 30, 2017 | 41.28M |
| March 31, 2017 | 35.91M |
| December 31, 2016 | 33.17M |
| September 30, 2016 | 29.58M |
| June 30, 2016 | 28.56M |
| March 31, 2016 | 23.09M |
| December 31, 2015 | 20.28M |
| September 30, 2015 | 19.00M |
| June 30, 2015 | 17.75M |
| March 31, 2015 | 14.67M |
| December 31, 2014 | 14.11M |
| September 30, 2014 | 12.13M |
| June 30, 2014 | 11.10M |
| March 31, 2014 | 8.249M |
Revenues Definition
Revenues measure the total amount of value that a company brings in during a certain period. This is also considered the "top-line" of the income statement. Revenues are used for all operating expenses as well as other line items which eventually lead to the net income for the company. Revenue is an extremely important metric when analyzing a company. A company with efficient margins is able to turn revenues into the most net income.
Revenue (Quarterly) Range, Past 5 Years
31.56M
Minimum
Jun 2020
85.62M
Maximum
Mar 2024
69.26M
Average
71.98M
Median
Revenue (Quarterly) Benchmarks
| Boston Scientific Corp | 3.856B |
| Globus Medical Inc | 616.53M |
| PROCEPT BioRobotics Corp | 44.54M |
| Accuray Inc | 101.13M |
| Asensus Surgical Inc | 5.431M |
Revenue (Quarterly) Related Metrics
| Net Income (Quarterly) | -40.84M |
| Total Expenses (Quarterly) | 112.96M |
| EPS Diluted (Quarterly) | -0.82 |
| Enterprise Value | 5.449B |
| Gross Profit Margin (Quarterly) | 76.34% |
| Profit Margin (Quarterly) | -47.70% |
| Earnings Yield | -2.67% |
| Normalized Earnings Yield | -2.460 |